CBT

Value 202020212022202320242025 TTM Total revenue 2.61 B3.41 B4.32 B3.93 B3.99 B3.71 B 3.61 B Gross profit 500 M799 M885 M839 M960 M940 M 916 M Operating expenses 369 M356 M290 M314 M360 M331 M 341 M Selling/general/admin expenses 292 M289 M258 M253 M283 M260 M 263 M Research & development 57 M56 M55 M57 M63 M59 M 58 M Operating income 21 M454 M389 M526 M614 M621 M 595 M Non-Operating Income, Total 17 M15 M44 M56 M68 M34 M 34 M Interest expense, net of interest capitalized 53 M49 M56 M90 M81 M76 M 76 M Non-Operating Income, excl. Interest Expenses -45 M-41 M-21 M-50 M-49 M-49 M -49 M Unusual income/expense 9 M7 M9 M16 M36 M7 M — Pretax income 36 M409 M345 M456 M535 M572 M 546 M Equity in earnings 3 M3 M10 M5 M6 M7 M 7 M Taxes 191 M123 M102 M-28 M111 M196 M 192 M Non-controlling/minority interest 17 M36 M34 M39 M44 M45 M 43 M After tax other income/expense -8 M-21 M-20 M-4 M-63 M-24 M — Net income before discontinued operations 238 M250 M209 M445 M380 M331 M 311 M Discontinued operations —————— — Net income 238 M250 M209 M445 M380 M331 M 311 M Dilution adjustment —-2 M-2 M——— — Preferred dividends —1 M1 M——— — Diluted net income available to common stockholders -238 M247 M206 M437 M374 M326 M 306 M Basic earnings per share (Basic EPS) -4.214.353.657.796.796.07 5.76 Diluted earnings per share (Diluted EPS) -4.214.343.627.736.726.02 5.72 Average basic shares outstanding 56.6 M56.7 M56.5 M56.1 M55.1 M53.7 M 213.9 M Diluted shares outstanding 56.6 M56.8 M56.9 M56.5 M55.7 M54.2 M 215.3 M EBITDA 289 M603 M741 M669 M751 M763 M 733 M EBIT 131 M443 M595 M525 M600 M609 M 575 M Cost of revenue 2.11 B2.61 B3.44 B3.09 B3.03 B2.77 B 2.69 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 158 M160 M146 M144 M151 M154 M 158 M